Company Filing History:
Years Active: 2020
Title: David Conca - Innovator in Pharmaceutical Formulations
Introduction
David Conca is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. His work focuses on enhancing the efficacy of treatments through advanced chemical compounds.
Latest Patents
David Conca holds a patent for pharmaceutical formulations of a HIF hydroxylase inhibitor. The patent, titled "Pharmaceutical formulations of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid and methods of use thereof," showcases his expertise in creating effective therapeutic solutions. This formulation aims to improve treatment options for various medical conditions.
Career Highlights
Throughout his career, David has been associated with Fibrogen, Inc., a company dedicated to developing innovative therapies for serious diseases. His role at Fibrogen has allowed him to work on cutting-edge research and contribute to the advancement of pharmaceutical science. He has successfully secured 1 patent that reflects his commitment to innovation in the industry.
Collaborations
David Conca has collaborated with esteemed colleagues, including Lee Allen Flippin and Scott D Leigh. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research and development efforts.
Conclusion
David Conca's contributions to pharmaceutical formulations exemplify the impact of innovation in healthcare. His work continues to pave the way for new treatment options, demonstrating the importance of research and collaboration in the field.